Patent: 10,953,098
Summary for Patent: 10,953,098
| Title: | Chemical structures for localized delivery of therapeutic agents |
| Abstract: | The present invention provides a method for selective delivery of a therapeutic or diagnostic agent to a targeted organ or tissue by implanting a biocompatible solid support in the patient being linked to a first binding agent, and administering a second binding agent to the patient linked to the therapeutic or diagnostic agent, such that the therapeutic or diagnostic agent accumulates at the targeted organ or tissue. |
| Inventor(s): | Jose Manuel Mejia Oneto, Ziyad F. Al-Rashid |
| Assignee: | ALCHEMICAL RESEARCH HOLDINGS LLC , University of California San Diego UCSD |
| Application Number: | US16/149,628 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,953,098
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Glaxosmithkline Biologicals | SHINGRIX | zoster vaccine recombinant, adjuvanted | Injection | 125614 | October 20, 2017 | 10,953,098 | 2038-10-02 |
| Glaxosmithkline Biologicals | SHINGRIX | zoster vaccine recombinant, adjuvanted | For Injection | 125614 | July 23, 2021 | 10,953,098 | 2038-10-02 |
| Glaxosmithkline Biologicals | SHINGRIX | zoster vaccine recombinant, adjuvanted | Injection | 125614 | July 16, 2025 | 10,953,098 | 2038-10-02 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 10,953,098
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| China | 105611914 | ⤷ Start Trial |
| European Patent Office | 3010486 | ⤷ Start Trial |
| Spain | 2966631 | ⤷ Start Trial |
| Japan | 2016522261 | ⤷ Start Trial |
| Japan | 2019089794 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
